JP2005507381A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005507381A5 JP2005507381A5 JP2003523181A JP2003523181A JP2005507381A5 JP 2005507381 A5 JP2005507381 A5 JP 2005507381A5 JP 2003523181 A JP2003523181 A JP 2003523181A JP 2003523181 A JP2003523181 A JP 2003523181A JP 2005507381 A5 JP2005507381 A5 JP 2005507381A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- dibromo
- isopropyl
- hydroxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0120691A GB0120691D0 (en) | 2001-08-24 | 2001-08-24 | Novel Compounds |
| GB0207719A GB0207719D0 (en) | 2002-04-03 | 2002-04-03 | Novel compounds |
| PCT/EP2002/009120 WO2003018515A2 (en) | 2001-08-24 | 2002-08-13 | Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005507381A JP2005507381A (ja) | 2005-03-17 |
| JP2005507381A5 true JP2005507381A5 (cg-RX-API-DMAC7.html) | 2006-06-22 |
Family
ID=26246475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003523181A Pending JP2005507381A (ja) | 2001-08-24 | 2002-08-13 | 心臓障害および代謝障害の治療のための主要環置換甲状腺受容体アンタゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7279593B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1499578A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005507381A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20040027927A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002331145B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2449515A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL159006A0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003018515A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL160845A0 (en) * | 2001-09-14 | 2004-08-31 | Tularik Inc | Linked biaryl compounds |
| EP2428516A1 (en) | 2003-11-19 | 2012-03-14 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
| GB0406380D0 (en) * | 2004-03-22 | 2004-04-21 | Karobio Ab | Novel pharmaceutical compositions |
| US20090232879A1 (en) | 2005-05-26 | 2009-09-17 | Metabasis Therapeutics, Inc. | Thyromimetics for the Treatment of Fatty Liver Diseases |
| KR101396606B1 (ko) | 2009-04-20 | 2014-05-16 | 미쓰비시 타나베 파마 코퍼레이션 | 신규 갑상선 호르몬 β 수용체 작동약 |
| WO2018094265A2 (en) | 2016-11-21 | 2018-05-24 | Viking Therapeutics, Inc. | Method of treating glycogen storage disease |
| AU2018280118B2 (en) | 2017-06-05 | 2021-07-15 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis |
| EP3683306A4 (en) | 2017-09-14 | 2021-06-09 | Riken | METHOD FOR MANUFACTURING RETINAGE TISSUE |
| EA202091979A1 (ru) | 2018-03-22 | 2021-06-22 | Вайкинг Терапьютикс, Инк. | Кристаллические формы и способы получения кристаллических форм соединения |
| EP4775207A2 (en) | 2018-12-05 | 2026-07-15 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis |
| SG11202109855PA (en) | 2019-03-13 | 2021-10-28 | Sumitomo Dainippon Pharma Co Ltd | Method for evaluating quality of transplant neural retina, and transplant neural retina sheet |
| EP4161925A4 (en) | 2020-06-09 | 2024-09-04 | Viking Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES |
| JPWO2022054925A1 (cg-RX-API-DMAC7.html) | 2020-09-11 | 2022-03-17 | ||
| EP4201428A4 (en) | 2020-09-11 | 2024-09-11 | Sumitomo Pharma Co., Ltd. | MEDIUM FOR TISSUE INTENDED FOR TRANSPLANTATION |
| KR20240103018A (ko) | 2021-11-19 | 2024-07-03 | 고쿠리쓰 겐큐 가이하쓰 호징 리가가쿠 겐큐소 | 시트상 망막 조직의 제조 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8501372D0 (en) | 1985-01-18 | 1985-02-20 | Smith Kline French Lab | Chemical compounds |
| EP0580550B1 (en) * | 1992-07-21 | 1997-10-22 | Novartis AG | Oxamic acid derivatives as hypocholesteremic agents |
| JPH11508241A (ja) | 1995-06-07 | 1999-07-21 | カロ バイオ エービー | 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用 |
| GB9713739D0 (en) | 1997-06-27 | 1997-09-03 | Karobio Ab | Thyroid receptor ligands |
| GB9816935D0 (en) * | 1998-08-05 | 1998-09-30 | Karobio Ab | Novel glucocortoid and thyroid receptor ligands for the treatment of metabolic disorders |
| GB9828442D0 (en) | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
| GB9927056D0 (en) | 1999-11-17 | 2000-01-12 | Karobio Ab | Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| KR20020089420A (ko) | 2000-03-31 | 2002-11-29 | 화이자 프로덕츠 인코포레이티드 | 갑상선 수용체 리간드로서의 말로남산 및 그의 유도체 |
| AU4884701A (en) | 2000-05-12 | 2001-11-20 | Kissei Pharmaceutical Co. Ltd. | Malonanilic acid derivatives, medicinal compositions containing the same and usethereof |
-
2002
- 2002-08-13 KR KR10-2004-7002447A patent/KR20040027927A/ko not_active Ceased
- 2002-08-13 EP EP02767384A patent/EP1499578A2/en not_active Withdrawn
- 2002-08-13 AU AU2002331145A patent/AU2002331145B2/en not_active Ceased
- 2002-08-13 US US10/485,849 patent/US7279593B2/en not_active Expired - Fee Related
- 2002-08-13 CA CA002449515A patent/CA2449515A1/en not_active Abandoned
- 2002-08-13 WO PCT/EP2002/009120 patent/WO2003018515A2/en not_active Ceased
- 2002-08-13 IL IL15900602A patent/IL159006A0/xx unknown
- 2002-08-13 JP JP2003523181A patent/JP2005507381A/ja active Pending